# A-EYE: A Mixed Quantitative and Qualitative Study to Develop and Evaluate the Application of Artificial Intelligence (AI) Methods Using Retinal Imaging for the Identification of Adverse Retinal Changes Associated With Cancer Therapies.

> **NCT04901468** · — · UNKNOWN · sponsor: **University of Manchester** · enrollment: 350 (estimated)

## Conditions studied

- All Comers

## Interventions

- **OTHER:** No Intervention

## Key facts

- **NCT ID:** NCT04901468
- **Lead sponsor:** University of Manchester
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-18
- **Primary completion:** 2022-12-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2022-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04901468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04901468, "A-EYE: A Mixed Quantitative and Qualitative Study to Develop and Evaluate the Application of Artificial Intelligence (AI) Methods Using Retinal Imaging for the Identification of Adverse Retinal Changes Associated With Cancer Therapies.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04901468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*